BNP Paribas Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
958,089
+65,801
| +7% | +$2.37M | 0.08% | 235 |
|
|
2025
Q1 | $27.8M | Buy |
892,288
+262,348
| +42% | +$8.17M | 0.07% | 258 |
|
|
2024
Q4 | $16.1M | Sell |
629,940
-4,561
| -0.7% | -$116K | 0.04% | 384 |
|
|
2024
Q3 | $18M | Buy |
634,501
+234,991
| +59% | +$6.65M | 0.04% | 326 |
|
|
2024
Q2 | $10.5M | Buy |
399,510
+217,767
| +120% | +$5.74M | 0.03% | 414 |
|
|
2024
Q1 | $5.52M | Buy |
181,743
+19,642
| +12% | +$597K | 0.01% | 512 |
|
|
2023
Q4 | $4.55M | Buy |
162,101
+1,044
| +0.6% | +$29.3K | 0.01% | 536 |
|
|
2023
Q3 | $4.37M | Buy |
161,057
+19,626
| +14% | +$533K | 0.01% | 543 |
|
|
2023
Q2 | $4.35M | Buy |
141,431
+103,863
| +276% | +$3.19M | 0.01% | 547 |
|
|
2023
Q1 | $1.35M | Sell |
37,568
-2,771
| -7% | -$99.9K | ﹤0.01% | 726 |
|
|
2022
Q4 | $1.59M | Buy |
40,339
+15,732
| +64% | +$622K | 0.01% | 705 |
|
|
2022
Q3 | $989K | Buy |
+24,607
| New | +$989K | ﹤0.01% | 759 |
|